Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies
塞拉地帕治疗原发性胆汁性胆管炎合并代偿性肝硬化患者的疗效和安全性:RESPONSE 和 ASSURE 研究的结果
期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000918
Gordon, Stuart C; Villamil, Alejandra; Jacobson, Ira M; Lawitz, Eric J; Younes, Ziad; Silveira, Marina G; Bowlus, Christopher L; Drenth, Joost P H; Vierling, John M; Morgera, Ulrike; Vasura, Adam; Dalekos, George; Galli, Andrea; Rabinovitz, Mordechai; Heo, Jeong; Nevens, Frederik; Levy, Cynthia; Zhou, Yan; Carroll, Susheela; Crittenden, Daria B